The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality
Open accessAbstract
BACKGROUND: Data on the association between subclinical thyroid dysfunction and coronary heart disease (CHD) and mortality are conflicting. PURPOSE: To summarize prospective evidence about the relationship between subclinical thyroid dysfunction and CHD and mortality. DATA SOURCES: MEDLINE (1950 to January 2008) without language restrictions and reference lists of retrieved articles were searched. STUDY SELECTION: Two reviewers screened and selected cohort studies that measured thyroid function and then followed persons prospectively to assess CHD or mortality. DATA EXTRACTION: By using a standardized protocol and forms, 2 reviewers independently abstracted and assessed studies. DATA SYNTHESIS: Ten of 12 identified studies involved population-based cohorts that included 14 449 participants. All 10 population-based cohort studies examined risks associated with subclinical hypothyroidism (2134 CHD events and 2822 deaths), whereas only 5 examined risks associated with subclinical hyperthyroidism (1392 CHD events and 1993 deaths). In a random-effects model, the relative risk (RR) for subclinical hypothyroidism for CHD was 1.20 (95% CI, 0.97 to 1.49; P for heterogeneity = 0.14; I(2 )= 33.4%). Risk estimates were lower when higher-quality studies were pooled (RR, 1.02 to 1.08) and were higher among participants younger than 65 years (RR, 1.51 [CI, 1.09 to 2.09] for studies with mean participant age <65 years and 1.05 [CI, 0.90 to 1.22] for studies with mean participant age > or =65 years). The RR was 1.18 (CI, 0.98 to 1.42) for cardiovascular mortality and 1.12 (CI, 0.99 to 1.26) for total mortality. For subclinical hyperthyroidism, the RR was 1.21 (CI, 0.88 to 1.68) for CHD, 1.19 (CI, 0.81 to 1.76) for cardiovascular mortality, and 1.12 (CI, 0.89 to 1.42) for total mortality (P for heterogeneity >0.50; I(2 )= 0% for all studies). LIMITATIONS: Individual studies adjusted for different potential confounders, and 1 study provided only unadjusted data. Publication bias or selective reporting of outcomes could not be excluded. CONCLUSION: Subclinical hypothyroidism and hyperthyroidism may be associated with a modest increased risk for CHD and mortality, with lower risk estimates when pooling higher-quality studies and larger CIs for subclinical hyperthyroidism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cardiovascular morbidity and mortality are particularly increased in men, in elderly patients with high-normal FT 4 levels and in patients with underlying heart disease [71-73, 76, 77, 87, 91, 92, 94] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [91]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Two did not find a link between SHyper and mortality [89,90] , whereas four other meta-analyses found an association between SHyper and cardiovascular or all-cause mortality [71,[91][92][93] , especially in elderly patients and in patients with co-morbidities [91,92] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [91]
Experimental — accuracy not yet measuredIn the citing paper
“Thus, suppressed TSH has in population studies consistently been associated with a higher mortality and other adverse effects compared to people with normal or even higher TSH concentrations ( Table 5 ) (87–90).”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
The Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE
Woolf, B. (1955) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1955.tb01348.x · Cited by 2,724
Ryan, T. J., Faxon, D. P., Gunnar, R. M., Kennedy, J. W., King, S. B., Loop, F. D., Peterson, K. L., Reeves, T. J., Williams, D. O., & Winters, W. L. (1988) · Circulation · doi:10.1161/01.cir.78.2.486 · Cited by 2,123
Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA · doi:10.1001/jama.291.2.228 · Cited by 1,800
Hak, A. E., Pols, H. A. P., Visser, T. J., Drexhage, H. A., Hofman, A., & Witteman, J. C. M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00004 · Cited by 1,336
Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease
(2003) · Thyroid · doi:10.1089/105072503321086962 · Cited by 1,212
Fibrinogen as a Cardiovascular Risk Factor
Ernst, E., & Resch, K. L. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-12-199306150-00008 · Cited by 992
Designing clinical research: An epidemiologic approach
Hulley, S., Cummings, S., & Browner, W. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90023-8 · Cited by 946
Thyroid Status, Disability and Cognitive Function, and Survival in Old Age
Gussekloo, J. (2004) · JAMA · doi:10.1001/jama.292.21.2591 · Cited by 899
Self-citationThyroid Status, Cardiovascular Risk, and Mortality in Older Adults
Cappola, A. R., Fried, L. P., Arnold, A. M., Danese, M. D., Kuller, L. H., Burke, G. L., Tracy, R. P., & Ladenson, P. W. (2006) · JAMA · doi:10.1001/jama.295.9.1033 · Cited by 862
Systematic reviews of evaluations of prognostic variables
Altman, D. G. (2001) · BMJ · doi:10.1136/bmj.323.7306.224 · Cited by 756
Parle, J. V., Maisonneuve, P., Sheppard, M. C., Boyle, P., & Franklyn, J. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06067-6 · Cited by 669
American Thyroid Association guidelines for detection of thyroid dysfunction.
Ladenson, P., Singer, P., Ain, K., Bagchi, N., Bigos, S., Levy, E., Smith, S. A., Daniels, G., & Cohen, H. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.11.1573 · Cited by 658
Smith, S. C., DOVE, J. T., Jacobs, A. K., Kennedy, J. W., Kereiakes, D. J., Kern, M. J., Kuntz, R. E., Popma, J. J., Schaff, H. V., Williams, D. O., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01344-4 · Cited by 645
Fade, J. V., Franklyn, J. A., Cross, K. W., Jones, S. C., & Sheppard, M. C. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01739.x · Cited by 567
Optimal Vitamin D Status for Colorectal Cancer Prevention
Gorham, E. D., Garland, C. F., Garland, F. C., Grant, W. B., Mohr, S. B., Lipkin, M., Newmark, H. L., Giovannucci, E. L., Wei, M. Y., & Holick, M. F. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.11.004 · Cited by 540
Subclinical thyroid dysfunction as a risk factor for cardiovascular disease
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O’Leary, P., Leedman, P. J., Feddema, P., & Michelangeli, V. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2467 · Cited by 536
Cooper, D. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450406 · Cited by 531
Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death
Rodondi, N., Newman, A. B., Vittinghoff, E., de Rekeneire, N., Satterfield, S., Harris, T. B., & Bauer, D. C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2460 · Cited by 503
Self-citationSazawal, S., & Black, R. (2003) · Lancet. Infectious Diseases (Print) · doi:10.1016/s1473-3099(03)00737-0 · Cited by 485
Approaches to heterogeneity in meta‐analysis
Petitti, D. B. (2001) · Statistics in Medicine · doi:10.1002/sim.1091 · Cited by 469
Sawin, C. T. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.145.8.1386 · Cited by 439
Monzani, F., Caraccio, N., Kozàkowà, M., Dardano, A., Vittone, F., Virdis, A., Taddei, S., Palombo, C., & Ferrannini, E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031669 · Cited by 399
Risk for Ischemic Heart Disease and All-Cause Mortality in Subclinical Hypothyroidism
Imaizumi, M., Akahoshi, M., Ichimaru, S., Nakashima, E., Hida, A., Soda, M., Usa, T., Ashizawa, K., Yokoyama, N., Maeda, R., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031089 · Cited by 373
The Aging Thyroid: Thyroid Deficiency in the Framingham Study
Sawin, C. T. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.1985.00360080056006 · Cited by 344
Thyroid hormone replacement for subclinical hypothyroidism
Villar, H. C. C. E., Saconato, H., Valente, O., & Atallah, Á. N. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003419.pub2 · Cited by 329
Helfand, M. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-2-200401200-00015 · Cited by 302
Thyroid Hormone Concentrations, Disease, Physical Function, and Mortality in Elderly Men
van den Beld, A. W., Visser, T. J., Feelders, R. A., Grobbee, D. E., & Lamberts, S. W. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0872 · Cited by 294
Association between increased mortality and mild thyroid dysfunction in cardiac patients
Iervasi, G. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.14.1526 · Cited by 285
Kvetny, J., Heldgaard, P. E., Bladbjerg, E. M., & Gram, J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02088.x · Cited by 280
LDL/HDL‐CHANGES IN SUBCLINICAL HYPOTHYROIDISM: POSSIBLE RISK FACTORS FOR CORONARY HEART DISEASE
Althaus, B., Staub, J. J., LÈCHE, A. R., OBERHÄNSLI, A., & Stähelin, H. B. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb03651.x · Cited by 243
Singh, S., Duggal, J., Molnar, J., Maldonado, F., Barsano, C. P., & Arora, R. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.02.027 · Cited by 243
Psaty, B. M., Anderson, M. L., Kronmal, R. A., Tracy, R. P., Orchard, T. J., Fried, L. P., Lumley, T., Robbins, J. A., Burke, G. L., Newman, A. B., et al. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52455.x · Cited by 208
Subclinical Hypothyroidism and the Risk of Coronary Heart Disease: A Meta-Analysis
Rodondi, N., Aujesky, D., Vittinghoff, E., Cornuz, J., & Bauer, D. C. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.09.028 · Cited by 207
Self-citationVanderpump, M. P. J., Tunbridge, W. M. G., French, J. M., Appleton, D. R., Bates, D., Clark, F., Evans, J. G., Rodgers, H., Tunbridge, F. K. E., & Young, E. T. (1996) · PubMed · doi:10.1089/thy.1996.6.155 · Cited by 207
HYPERTHYROIDISM IN PATIENTS OVER THE AGE OF 60 YEARS: CLINICAL FEATURES IN 85 PATIENTS
DAVIS, P. J., & DAVIS, F. B. (1974) · Medicine · doi:10.1097/00005792-197405000-00001 · Cited by 206 · cited 1×
“Excluded (n = 20) No specific data on subclinical hypothyroidism or hyperthroldism, deflned as an elevated or low TSH level (43, 45-53): 10 No prospective data on outcomes f------+ (54-60): 7 No numerlcal data on outcomes (44): 1 Ali patients treated for thyroid dysfunctlon (61 ): 1 Reported the same study already sel…”
BackgroundInvited commentary: benefits of heterogeneity in meta-analysis of data from epidemiologic studies
Berlin, J. A. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117645 · Cited by 191
Carrero, J. J., Qureshi, A. R., Axelsson, J., Yılmaz, M. İ., Rehnmark, S., Witt, M. R., Barany, P. F., Heimbürger, O., Suliman, M. E., Alvestrand, A., et al. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01865.x · Cited by 190
RELATIONSHIP OF ALTERED THYROID HORMONE INDICES TO SURVIVAL IN NONTHYROIDAL ILLNESSES
Kaptein, E. M., Weiner, J. M., ROBINSON, W. J., Wheeler, W. S., & Nicoloff, J. T. (1982) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1982.tb03173.x · Cited by 167
Retaining and Tracking Cohort Study Members
Hunt, J. R., & White, E. (1998) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017972 · Cited by 162
SERUM THYROID-STIMULATING HORMONE MEASUREMENT FOR ASSESSMENT OF THYROID FUNCTION AND DISEASE
Ross, D. S. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70186-9 · Cited by 141
Cardiovascular Manifestations of Hyperthyroidism Before and After Antithyroid Therapy
Osman, F., Franklyn, J. A., HOLDER, R. L., Sheppard, M. C., & GAMMAGE, M. D. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.042 · Cited by 137
Mortality and Vascular Outcomes in Patients Treated for Thyroid Dysfunction
Flynn, R. W. V., MacDonald, T. M., Jung, R. T., Morris, A. D., & Leese, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1833 · Cited by 136
Bell, R. J., Rivera‐Woll, L., Davison, S. L., Topliss, D. J., Donath, S. M., & Davis, S. R. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02771.x · Cited by 129
Enia, G., Panuccio, V. A., Cutrupi, S., Pizzini, P., Tripepi, G. L., Mallamaci, F., & Zoccali, C. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl605 · Cited by 120
Völzke, H., Schwahn, C., Wallaschofski, H., & Dörr, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0179 · Cited by 120
Cancer mortality in women with thyroid disease.
GOLDMAN, M. B., Monson, R. R., & Maloof, F. (1990) · PubMed · Cited by 116
Association Between Thyroid Dysfunction and Total Cholesterol Level in an Older Biracial Population
Kanaya, A. M., Harris, F., Volpato, S., Pérez‐Stable, E. J., Harris, T. B., & Bauer, D. C. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.7.773 · Cited by 116
Self-citationLow triiodothyronine: a strong predictor of outcome in acute stroke patients
Alevizaki, M. K., Synetou, M., Xynos, K., Παππά, Θ., & Vemmos, K. N. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01839.x · Cited by 115
Friberg, L., Drvota, V., Bjelak, A. H., Eggertsen, G., & Ahnve, S. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00980-9 · Cited by 101
Thyroid Disease and Increased Cardiovascular Risk
Nyirenda, M., Clark, D. N., Finlayson, A. R., Read, J., Elders, A., Bain, M., Fox, K. A. A., & Toft, A. D. (2005) · Thyroid · doi:10.1089/thy.2005.15.718 · Cited by 89
Thyroid Hormone Use, Hyperthyroidism and Mortality in Older Women
Bauer, D. C., Rodondi, N., Stone, K. L., & Hillier, T. A. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.04.034 · Cited by 71
Self-citationExcess Triiodothyronine as a Risk Factor of Coronary Events
Peters, A., Ehlers, M., Blank, B., Exler, D., Falk, C., Kohlmann, T., Fruehwald‐Schultes, B., Wellhoener, P., Kerner, W., & Fehm, H. L. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.13.1993 · Cited by 61
Thyroid Disease in the Oldest Old
Cooper, D. S. (2004) · JAMA · doi:10.1001/jama.292.21.2651 · Cited by 51
Thyroid autoimmunity and cardiovascular diseases
Aho, K., Gordin, A., Palosuo, T., Punsar, S., Valkeila, E., KARVONEN, M. J., Inkovaara, J., & Pasternack, A. I. (1984) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a061550 · Cited by 24
Waterhouse, D. F., McLaughlin, A. M., Walsh, C., Sheehan, F., & O'Shea, D. B. (2007) · Thyroid · doi:10.1089/thy.2006.0208 · Cited by 22
Radácsi, A., Dohán, O., Kovács, G. L., Bernard, W., Feldkamp, J., Horster, F. A., & Szabolcs, I. (2003) · Endocrine · doi:10.1385/endo:21:2:133 · Cited by 21
Singer, R. B. (2006) · PubMed · Cited by 15
Hypothyroidism and coronary heart disease.
Bastenie, P. A. (1982) · PubMed · Cited by 15
Hormone Replacement Therapy and Vascular Risk Disorders in Adult Hypopituitarism
Kaji, H., Iida, K., Takahashi, Y., et al. (2007) · Endocrine Journal · doi:10.1507/endocrj.k06-129 · Cited by 14
The negative role of subclinical thyrotoxicosis on the outcome of hospitalized geriatric patients.
Bossoni, S., Cossi, S., Marengoni, A., Martinis, M. D., Calabrese, P. A., Leonardi, R., Giustina, A., Romanelli, G., & Grassi, V. (2002) · PubMed · Cited by 9
Association between subclinical hypothyroidism and coronary heart disease in 2006
Rodondi, N., Newman, A. B., Cappola, A. R., & Bauer, D. C. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.07.133 · Cited by 6
Self-citationKent, S. (1979) · PubMed · Cited by 5
Popovici, D. I. (1981) · PubMed · Cited by 1
Research works printed but not linked: 10
- Villar H, 2007, Cochrane Database Syst Rev, CD003419
- Vanderpump MP, 1996, Thyroid, 6, 155
- Tobias A, 1999, Stata Tech Bull, 47, 15
- Goldman MB, 1990, Cancer Res, 50, 2283
- Bossoni S, 2002, J Endocrinol Invest, 25, 64
- Bastenie PA, 1982, Acta Cardiol, 37, 365
- Kent S, 1979, Geriatrics, 34, 97
- Popovici D, 1980, Endocrinologie, 18, 293
- Singer RB, 2006, J Insur Med, 38, 14
- Rodondi N, 2007, Int J Cardiol
Cited by
Sorted by citations
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality
Rodondi, N., den Elzen, W. P. J., Bauer, D. C., Cappola, A. R., Razvi, S., Walsh, J. P., Åsvold, B. O., Iervasi, G., Imaizumi, M., Collet, T.-H., et al. (2010) · JAMA · doi:10.1001/jama.2010.1361 · Cited by 1,216
Self-citationBahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053
Cooper, D. S., & Biondi, B. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60276-6 · Cited by 1,039
Metadata
- Authors
- Ochs, N., Auer, R., Bauer, D. C., Nanchen, D., Gussekloo, J., Cornuz, J., & Rodondi, N.
- Affiliations
- University of California, San Francisco (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2008-06-03
- Volume
- 148
- Issue
- 11
- Pages
- 832-845
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2120863778
- Cited by
- 477
- References
- 70
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 10 · 2023: 15 · 2022: 19 · 2021: 18 · 2020: 26 · 2019: 27 · 2018: 22 · 2017: 29 · 2016: 32 · 2015: 30 · 2014: 36 · 2013: 40 · 2012: 46
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- green
- iris.unil.ch
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- subclinical thyroid dysfunction, subclinical hypothyroidism, subclinical hyperthyroidism, coronary artery disease, cardiovascular mortality, all-cause mortality, thyroid function, prospective cohort, age as confounder, study quality heterogeneity, relative risk estimation, subgroup analysis
- MeSH terms
- Coronary Disease, Female, Humans, Hyperthyroidism, Hypothyroidism, Male, Prospective Studies, Risk Factors, Thyroid Function Tests, Thyrotropin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review